Achillion Pharmaceuticals Stock Net Income
Achillion Pharmaceuticals fundamentals help investors to digest information that contributes to Achillion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Achillion Pink Sheet. The fundamental analysis module provides a way to measure Achillion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achillion Pharmaceuticals pink sheet.
Achillion |
Achillion Pharmaceuticals Company Net Income Analysis
Achillion Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Achillion Pharmaceuticals Net Income | (51 K) |
Most of Achillion Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achillion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Achillion Pharmaceuticals reported net income of (51,000). This is 100.0% lower than that of the Communication Services sector and significantly lower than that of the Advertising Agencies industry. The net income for all United States stocks is 100.01% higher than that of the company.
Achillion Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achillion Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Achillion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Achillion Pharmaceuticals by comparing valuation metrics of similar companies.Achillion Pharmaceuticals is currently under evaluation in net income category among its peers.
Achillion Fundamentals
| Return On Equity | -0.0023 | |||
| Return On Asset | -115.43 | |||
| Operating Margin | (586.17) % | |||
| Current Valuation | 6.21 M | |||
| Shares Outstanding | 30 M | |||
| Shares Owned By Insiders | 97.61 % | |||
| Number Of Shares Shorted | 16.38 M | |||
| Price To Earning | (23.49) X | |||
| Price To Book | 4.00 X | |||
| Price To Sales | 710.14 X | |||
| Revenue | 8.7 K | |||
| Gross Profit | 7.87 K | |||
| EBITDA | (43.34 K) | |||
| Net Income | (51 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Total Debt | 61 K | |||
| Debt To Equity | 1.00 % | |||
| Current Ratio | 0.02 X | |||
| Cash Flow From Operations | (39.76 K) | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (0) X | |||
| Price To Earnings To Growth | (0.66) X | |||
| Number Of Employees | 56 | |||
| Beta | 1.59 | |||
| Market Capitalization | 6.18 M | |||
| Total Asset | 464.52 M | |||
| Retained Earnings | (653.45 M) | |||
| Working Capital | 447.93 M | |||
| Current Asset | 462.59 M | |||
| Current Liabilities | 14.66 M | |||
| Z Score | 59.2 |
Pair Trading with Achillion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Achillion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achillion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to GE Aerospace could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GE Aerospace when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GE Aerospace - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GE Aerospace to buy it.
The correlation of GE Aerospace is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GE Aerospace moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GE Aerospace moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GE Aerospace can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets |